Consolidated Statements of Operations - USD ($)		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014
Income Statement [Abstract]
Revenues	[1]	$ 6,536,992	$ 5,335,545
Costs and Expenses
Cost of revenues (exclusive of depreciation shown below)		9,562,528	0
Research, development and manufacturing operations (exclusive of depreciation shown below)		6,711,813	18,791,140
Selling, general and administrative (exclusive of depreciation shown below)		12,363,037	14,118,508
Depreciation and amortization		5,633,428	5,960,843
Impairment loss		12,570	324,031
Total Costs and Expenses		34,283,376	39,194,522
Loss from Operations		(27,746,384)	(33,858,977)
Other Income/(Expense)
Other Income/(Expense), net		(60,294)	(297,143)
Interest Expense		(26,549,098)	(4,109,272)
Deemed interest expense on warrant liability		(909,092)	(4,037,517)
Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net		9,467,070	(1,051,540)
Total Other Income/(Expense)		(18,051,414)	(9,495,472)
Net Loss		(45,797,798)	(43,354,449)
Deemed (non-cash) dividends on preferred stock and accretion of warrants		0	(8,087,500)
Net Loss applicable to common stockholders		$ (45,797,798)	$ (51,441,949)
Net Loss Per Share (Basic and diluted) (in dollars per share)		$ (0.86)	$ (4.85)
Weighted Average Common Shares Outstanding (Basic and diluted) (in shares)		53,475,729	10,598,502

[1] Includes related party revenue of $0 and $8,050 for the years ended December 31, 2015 and 2014, respectively. See Note 16.